A pre-clinical organoid model to select suitable bladder cancer patients for targeting EZH2 treatment

被引：0
|
作者：
Zhao, H. [1 ]
Liao, J. [2 ]
Liu, K. [1 ]
Chen, X. [1 ]
Wu, H. [1 ]
Chiu, P. K-F [1 ]
Ng, C-F [1 ]
Teoh, J. Y-C [1 ]
机构：
[1] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Peoples R China
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0592
引用
收藏
页码：S1501 / S1501
页数：1
相关论文
共 50 条
  • [31] Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7
    Veronika Bandara
    Jade Foeng
    Batjargal Gundsambuu
    Todd S. Norton
    Silvana Napoli
    Dylan J. McPeake
    Timona S. Tyllis
    Elaheh Rohani-Rad
    Caitlin Abbott
    Stuart J. Mills
    Lih Y. Tan
    Emma J. Thompson
    Vasiliki M. Willet
    Victoria J. Nikitaras
    Jieren Zheng
    Iain Comerford
    Adam Johnson
    Justin Coombs
    Martin K. Oehler
    Carmela Ricciardelli
    Allison J. Cowin
    Claudine S. Bonder
    Michael Jensen
    Timothy J. Sadlon
    Shaun R. McColl
    Simon C. Barry
    Nature Communications, 14
  • [32] Intermittent fasting in combination with PD-inhibitor treatment as an innovative treatment strategy in a pre-clinical model of obesity-driven endometrial cancer
    Haag, Jennifer
    Lara, Olivia
    Zhou, Chunxiao
    Hursting, Stephen D.
    Bae-Jump, Victoria
    CLINICAL CANCER RESEARCH, 2024, 30 (05)
  • [33] Efficacy of neratinib neoadjuvant therapy in a pre-clinical model of HER2+ve breast cancer brain metastasis
    Nagpal, Aadya
    Redvers, Rick P.
    Ayton, Scott
    Anderson, Robin
    Loi, Sherene
    Pouliot, Normand
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 61 - 61
  • [34] Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer
    Pierre, Fabrice
    Chua, Peter C.
    O'Brien, Sean E.
    Siddiqui-Jain, Adam
    Bourbon, Pauline
    Haddach, Mustapha
    Michaux, Jerome
    Nagasawa, Johnny
    Schwaebe, Michael K.
    Stefan, Eric
    Vialettes, Anne
    Whitten, Jeffrey P.
    Chen, Ta Kung
    Darjania, Levan
    Stansfield, Ryan
    Bliesath, Joshua
    Drygin, Denis
    Ho, Caroline
    Omori, May
    Proffitt, Chris
    Streiner, Nicole
    Rice, William G.
    Ryckman, David M.
    Anderes, Kenna
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2011, 356 (1-2) : 37 - 43
  • [35] Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer
    Fabrice Pierre
    Peter C. Chua
    Sean E. O’Brien
    Adam Siddiqui-Jain
    Pauline Bourbon
    Mustapha Haddach
    Jerome Michaux
    Johnny Nagasawa
    Michael K. Schwaebe
    Eric Stefan
    Anne Vialettes
    Jeffrey P. Whitten
    Ta Kung Chen
    Levan Darjania
    Ryan Stansfield
    Joshua Bliesath
    Denis Drygin
    Caroline Ho
    May Omori
    Chris Proffitt
    Nicole Streiner
    William G. Rice
    David M. Ryckman
    Kenna Anderes
    Molecular and Cellular Biochemistry, 2011, 356 : 37 - 43
  • [36] Intermittent fasting alone or in combination with paclitaxel as a highly effective treatment strategy in a pre-clinical model of obesity-driven endometrial cancer
    Newton, Meredith
    Burkett, Wesley
    Zhao, Ziyi
    Zhou, Chunxiao
    Lee, Douglas
    Milne, Ginger
    Coleman, Michael
    Shi, Qing
    Sherman, Mark
    Hursting, Stephen
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S38 - S38
  • [37] Intermittent Treatment with Parathyroid Hormone Overactivates Intratrabecular Tunneling, a Previously Overlooked Mode of Remodeling: A Randomized Clinical Trial in Patients with Hypoparathyroidism and Pre-Clinical Rabbit Model
    Thomsen, Lisbeth Koch
    Laursen, Kaja Sondergaard
    Rizvi, Ali R.
    Kim, Harrison
    Loundagin, Lindsay
    Wei, Xuan
    Sikjaer, Tanja Tvistholm
    Thomsen, Jesper Skovhus
    Andreasen, Christina Moeller
    Rejnmark, Lars
    Cooper, David Michael Lane
    Andersen, Thomas Levin
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 369 - 370
  • [38] On the pre-clinical validation of a commercial model-based optimisation engine: Application to volumetric modulated arc therapy for patients with lung or prostate cancer
    Fogliata, Antonella
    Belosi, Francesca
    Clivio, Alessandro
    Navarria, Piera
    Nicolini, Giorgia
    Scorsetti, Marta
    Vanetti, Eugenio
    Cozzi, Luca
    RADIOTHERAPY AND ONCOLOGY, 2014, 113 (03) : 385 - 391
  • [39] Antibody targeting soluble NKG2D ligand sMIC induces regression of primary tumors and eliminates metastasis in multiple pre-clinical cancer models
    Wu, Jennifer D.
    Basher, Fahmin
    Rubinstein, Mark
    CANCER RESEARCH, 2015, 75
  • [40] The treatment of patients with non-small cell lung cancer carrying uncommon EGFR mutations, HER2 mutations, or brain metastases: a systematic review of pre-clinical and clinical findings for dacomitinib
    Yang, Li-Li
    Luo, Xiao-Zhen
    Xie, Ling-Ling
    Lei, Xiao-Zhen
    Zhu, Jiang
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (08) : 2197 - 2211
12345